home / stock / pte / pte news


PTE News and Press, PolarityTE Inc. From 09/23/19

Stock Information

Company Name: PolarityTE Inc.
Stock Symbol: PTE
Market: NASDAQ
Website: polarityte.com

Menu

PTE PTE Quote PTE Short PTE News PTE Articles PTE Message Board
Get PTE Alerts

News, Short Squeeze, Breakout and More Instantly...

PTE - MNK, EXAS among premarket gainers

Plus Therapeutics (NASDAQ: PSTV ) +99%  on BARDA payment . More news on: Plus Therapeutics, Inc., Avadel Pharmaceuticals plc, Arotech Corporation, Stocks on the move, Read more ...

PTE - PolarityTE Announces Positive Data Showing SkinTE Regenerated Full-Thickness Skin in Difficult-to-Treat Wounds

SkinTE, a novel human cellular and tissue-based product derived from a patient’s own skin, was used to treat a variety of skin defects that failed conventional treatments Limitations of current treatment options create need for new therapies to treat increasing incidence of f...

PTE - PolarityTE to Attend the 2019 Cantor Global Healthcare Conference

PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present at the 2019 Cantor Global Healthcare Conference on Wednesday, October 2, 2019 in New York, NY. A live audio webcas...

PTE - SkinTE Data Including Final Pilot Study Data Readout to be Presented at the Symposium on Advanced Wound Care Fall Meeting

- Final Data Readout of Pilot Trial Evaluating SkinTE for Treatment of Venous Stasis Leg Ulcers Designated Highest Scoring Poster Abstract in the Conference’s Case Series/Study Category - Four Poster Abstracts Will Be Presented Demonstrating Positive Clinical Outcomes of SkinTE...

PTE - SkinTE Data to be Presented at the American Society of Plastic Surgeons 88th Annual Scientific Meeting

SALT LAKE CITY , Sept. 9, 2019 /PRNewswire/ --  PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that an abstract with data from 15 patient cases where the Company's SkinTE!...

PTE - PolarityTE Appoints Peter Cohen as Chairman of the Board

SALT LAKE CITY , Sept. 4, 2019 /PRNewswire/ --  PolarityTE, Inc. (Nasdaq: PTE) , a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced the appointment of Peter Cohen , previously Lead Director, as Chairman of the B...

PTE - PolarityTE: Inflection

A Roller Coaster Ride So you say you want to invest in biotech? Data by YCharts PolarityTE ( PTE ) is a commercial-stage biotech in the regenerative medicine field, where until now there has been much more promise than results. If new management can execute they have an insane amount...

PTE - PolarityTE to Attend H.C. Wainwright 21st Annual Healthcare Conference and Morgan Stanley 17th Annual Global Healthcare Conference

SALT LAKE CITY , Aug. 28, 2019 /PRNewswire/ --  PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, today announced that it will present at the H.C. Wainwright 21st Annual Healthcare Conference on...

PTE - Microcaps mostly among midday movers

Gainers:  Appliance Recycling Centers of America (NASDAQ: ARCI ) +95% . Arcadia Biosciences (NASDAQ: RKDA ) +31% . Koss Corporation (NASDAQ: KOSS ) +30% . U.S. Well Services (NASDAQ: USWS ) +24% . Salarius Pharmaceuticals (NASDAQ: SLRX ) +18% . J.Jill (NYSE: JILL ) +18% . Luby's...

PTE - PolarityTE Granted Canadian Patent

SALT LAKE CITY , Aug. 20, 2019 /PRNewswire/ --  PolarityTE, Inc. (Nasdaq: PTE), a biotechnology company developing and commercializing regenerative tissue products and biomaterials, announced today that the Canadian Intellectual Property Office has granted Patent No. 2 969 707 entit...

Previous 10 Next 10